Information for Attendees of the CMHC 2010 Annual Meeting

Article

The 2010 Cardiometabolic Health Congress will take place October 20-23, 2010, at the Sheraton Hotel, in Boston, MA.

WHAT: 2010 Cardiometabolic Health Congress,

WHERE: Sheraton Boston Hotel, Boston, Massachusetts

WHEN: October 20-23

Join colleagues at CMHC 2010, October 20-23, for current clinical updates in cardiometabolic medicine. The educational program, presented by an acclaimed faculty, addresses current clinical cardiology and endocrinology issues increasingly affecting the American public. The CMHC curriculum is designed to provide information on the most effective, current strategies for the prevention, diagnosis, and management of type 2 diabetes, atherosclerosis, hypertension, dyslipidemia, obesity, thrombosis, chronic kidney disease, and related comorbidities. Click here to register.

Conference Program

A PDF of the complete conference program is available for download.

Hotel and Travel Information

It’s a bit late in the day, but interested parties can find information about housing options, ground transportation, and Boston attractions here.

Exhibits and Exhibitors

The 2010 meeting will feature exhibit hours on Thursday, October 21 from 9-11:30 AM and 2:30-6:30PM; and Friday, October 22 from 9-11:30AM and 2:00-5:00PM. A wide range of exhibitors from medical laboratories to medical device makers will be available to discuss more on site.

Corporate Satellite Symposia

Some of the topics are:

Cardiometabolic Risk Reduction in Patients with T2DM: Expert Recommendations for Anti-hyperglycemic Therapy Selection to Achieve Optimal Outcomes

Overcoming Today’s Top Challenges in Ischemic Heart Disease: Clinical Controversies and Evidence-Based Solutions for Optimizing Patient Care

Individualizing and Optimizing Antiplatelet Therapy in High-Risk Patient Groups:

Moving Beyond a “One-Size-Fits-All” Approach

Recent Videos
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
Brendon Neuen, MBBS, PhD | Credit: X.com
© 2024 MJH Life Sciences

All rights reserved.